UBS AM’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.8M | Sell |
|
|||||
|
2025
Q2 | $12M | Buy |
|
|||||
|
2025
Q1 | $8.73M | Sell |
|
|||||
|
2024
Q4 | $8.5M | Buy |
|
|||||
|
2024
Q3 | $4.74M | Sell |
|
|||||
|
2024
Q2 | $6.89M | Buy |
|
|||||
|
2024
Q1 | $3.8M | Hold |
|
|||||
|
2023
Q4 | $3.29M | Sell |
|
|||||
|
2023
Q3 | $2.31M | Buy |
|
|||||
|
2023
Q2 | $3.75M | Hold |
|
|||||
|
2023
Q1 | $3.75M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.08M | Hold |
|
|||||
|
2022
Q2 | $1.19M | Buy |
|
|||||
|
2022
Q1 | $1.22M | Hold |
|
|||||
|
2021
Q4 | $1.05M | Hold |
|
|||||
|
2021
Q3 | $992K | Hold |
|
|||||
|
2021
Q2 | $1.21M | Buy |
|
|||||
|
2021
Q1 | $1.38M | Buy |
|
|||||
|
2020
Q4 | $1.08M | Buy |
|
|||||
|
2020
Q3 | $1.11M | Buy |
|
|||||
|
2020
Q2 | $976K | Buy |
|
|||||
|
2020
Q1 | $240K | Sell |
|
|||||
|
2019
Q4 | $641K | Buy |
|
|||||
|
2019
Q3 | $318K | Buy |
|
|||||
|
2019
Q2 | $322K | Hold |
|
|||||
|
2019
Q1 | $385K | Buy |
|
|||||
|
2018
Q4 | $316K | Sell |
|
|||||
|
2018
Q3 | $851K | Sell |
|
|||||
|
2018
Q2 | $1.3M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $7K | Sell |
|
|||||
|
2015
Q4 | $11K | Hold |
|
|||||
|
2015
Q3 | $56K | Hold |
|
|||||
|
2015
Q2 | $72K | Buy |
|
|||||
|
2015
Q1 | $56K | Buy |
|
|||||
|
2014
Q4 | $66K | Hold |
|
|||||
|
2014
Q3 | $75K | Hold |
|
|||||
|
2014
Q2 | $102K | Hold |
|
|||||
|
2014
Q1 | $108K | Hold |
|
|||||
|
2013
Q4 | $131K | Buy |
|
|||||
|
2013
Q3 | $136K | Hold |
|
|||||
|
2013
Q2 | $108K | Buy |
|